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ABSTRACT 
 
THE EFFECT OF SURFACE MODIFICATION OF  
BIOMATERIALS ON THE CELLULAR INTERACTIONS 
 
The preparation and characterization of chitosan-hydroxyapatite composite 
scaffolds and protein adsorption chracteristics of these scaffolds have been investigated 
in this study. The effects of different chitosan/hydroxyapatite contents of the low 
density composites on the protein adsorption behaviour were experimentally examined. 
Bradford method at 595 nm and 280 nm UV protein absorption methods were used for 
the determination of adsorbed amount of bovine serum albumin (BSA) and human 
serum protein (HSP). In this study low molecular weight chitosan and hydroxyapatite 
have been used for the preparation of the scaffold composites by freeze drying and SEM 
was used for microstructural analysis. The thermal behaviour of the composites was 
investigated by DSC and TGA. Composite scaffolds were prepared by using different 
amounts of chitosan and hydroxyapatite (HA) and six different scaffolds were prepared 
and coded as C100H0, C80H20, C70H30, C50H50, C30H70, and C20H80. The porous 
low density scaffolds had 93.5-96.3% porosity with a slight increase in density with 
increasing HA content. The interconnected pore network was formed from 50-250 μm 
relatively uniform size pores with thin pore walls. The HA particles were fully 
embedded in the polymer matrix in the pore walls. The TGA curves have shown that the 
freeze dried phase seperation induced biopolymer sturucture degrates at lower 
temperatures faster than the original raw polymer.  
           The adsorptions of BSA and HSP onto composites have been studied as a 
function of time, protein concentration and pH. Adsorption experiments were also 
conducted with commercial HA powder. The adsorption kinetics experiments have 
indicated that protein adsorption was almost completely achieved in the first 2-3 hours 
with relatively high uptake values of up to 45-60 mg/g and 40-60 mg/g for 595 nm 
Bradford and 280 nm methods. The adsorption behaviour did not fit to the commonly 
known Langmuir and Freundlich isotherms. This was attributed to the 
swelling/degradation tendency of the freeze-dried chitosan containing scaffolds. The 
HSP uptake of 30 and 50 wt% HA containing composites were in the 50-60 mg/g range 
which was higher than other composites and the raw unprocessed chitosan. 
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ÖZET 
 
BİYOMALZEMELERİN YÜZEY MODİFİKASYONUNUN HÜCRESEL 
ETKİLEŞİMLERE ETKİSİ 
 
Bu çalışmada kitosan-hidroksiapatit (HA) yapı iskelesi kompozitlerinin 
hazırlanması-karakterizasyonu ve protein adsorplama özellikleri araştırılmıştır. Bu 
düşük yoğunluklu malzemelerde değişen kitosan ve HA içeriğinin protein adsorplama 
davranışına etkileri incelenmiştir. Adsorplanan BSA ve HSP protein konsantrasyonları 
595 nm Bradford ve 280 nm absorbsiyona dayalı UV metotlarıyla saptanmıştır. Düşük 
molekül ağırlıklı kitosan ve HA bu gözenekli malzemelerin dondurmalı kurutmayla 
eldesinde kullanılmış ve malzemelerin mikroyapıları SEM kullanılarak incelenmiştir. 
Kompozitlerin ısıl davranışları TGA ve DSC kullanılarak saptanmıştır. 
 Kompozit yapı iskeleleri değişen ağırlık oranlarında kitosan ve HA kullanılarak 
hazırlanmış ve altı değişik malzeme C100H0, C80H20, C70H30, C50H50, C30H70 ve 
C20H80 olarak kodlanmıştır. Gözenekli çok düşük yoğunluklu yapıların 93.5-96.3 % 
gözeneğe sahip oldukları ve artan HA içeriğiyle yoğunluklugun ufak bir artış gösterdiği 
saptanmıştır. Kompozitlerin birbirine bağlantılı gözenek yapısının düzenli 50-250 μm 
boyutunda gözenekler ve ince gözenek duvarları içerdiği ve HA parçaçıklarının 
duvarlarda tamamen gömülü olduğu SEM incelemelerinde görülmüştür. Faz ayırma 
metodu ile üretilen biyopolimer yapısının orijinal ham polimerden düşük sıcaklıklarda 
daha hızlı parçalandığı TGA eğrilerinden gözlenmiştir. 
Kompozitlere BSA ve HSP adsorpsiyonu zaman, protein konsantrasyonu ve 
pH’nın değişimine karşılık incelenmiştir. Adsorpsiyon deneyleri aynı zamanda ticari 
HA tozuylada yürütülmüştür. Adsorpsiyon kinetiğiyle ilgili deneyler protein 
adsorsiyonunun hemen hemen 2-3 saat içerinde tamalandığını ve 595 nm Bradford ve 
280 nm protein UV absorpsiyonu metotlarına gore protein alımının 45-60 mg/g ve 40-
60 mg/g gibi yüksek düzeylere ulaşabildiğini göstermiştir. Kompozitlerin adsorpsiyon 
davranışlarının yaygın olarak bilinen Langmuir ve Freundlich izotermlerine uymadığı 
saptanmıştır. Bunun nedeninin dondurarak kurutulan kitosanın sulu ortamda 
şişmesi/bozunması olduğu düşünülmüştür. Yapı iskelelerinden 30 ve 50% HA içeren 
kompozitlerin HSP adsorpsiyon alımları 50-60 mg/g aralığında diğer örneklerden ve 
işlenmemiş kitosandan yüksek olarak saptanmıştır. 
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CHAPTER 1 
INTRODUCTION 
 
There is a necessity for replacing bone substance which has been lost due to 
traumatic or nontraumatic events (Suchanek, et al. 1998). The implanted biomaterial 
must have certain desired properties in order to achieve a satisfactory result and to have 
an appropriate host response at the hard tissue implantation site. The microstructural 
and mechanical properties of the bone must be thoroughly understood for the successful 
preparation of canditate hard tissue implant biomaterials in order to mimic the natural 
bone structure. 
Reconstructive treatment of the bone defects is a widespread practice. Several 
kinds of materials can be used in these procedures: autografts (obtained from the patient 
itself) allografts (homografts from humans, xenografts from animals), or implants made 
out of bone bonding biomaterials. Autologous vascularized bone grafts are the ‘golden 
standard’, but morbidity and pain at donor sites, the limited number of donor sites, the 
limits in size of the bone graft joined to the costs and time of a double surgery, have 
shifted the interest towards allografts. Allografts are not immune from drawbacks 
besides bacterial contamination. The major disadvantages of allografts includes the risk 
of induction of transmissible diseases in the recipient, and the graft tendency to elicit 
immune response which can lead to high failure rates. As a consequence the interests 
has shifted towards the use of implantable biomaterials, characterized by bone bonding 
properties and by a morphology simulating the one of cancellous bone. 
A biomaterial is any substance or combination of substances, which can be 
used for any period of time, as a whole or as a part of a system for use in the human 
body to measure, restore, and improve physiologic function, and enhance survival and 
quality of life. Typically, inorganic (metals, ceramics, and composites) and polymeric 
(synthetic and natural) materials have been used for such items as artificial heart-valves, 
(polymeric or carbon-based), synthetic blood-vessels, artificial hips (metallic or 
ceramic), medical adhesives, sutures, dental composites, and polymers for controlled 
slow drug delivery. Biomaterials must be compatible with body in order to exhibit their 
function properly. The use of incompatible materials as medical implants in the body 
 2
may induce unfavourable immune reactions, undesirable interactions with blood and 
other body fluids as well as damaging the genetic material at the chromosomal and 
DNA levels.  
Material biocompatibility is an essential prequisite for a successful functioning 
of any implant. Since the application area of biomaterials has been increasing rapidly, 
the interest for these materials has been also increasing which caused the development 
and the use of several biocompatibility testing methods to evaluate the biocompatibility 
of materials. The initial necessary phase of biocompatibility involves the adsorption of 
blood serum proteins onto the biomaterial surfaces. Protein adsorption is generally 
regarded as a primary event that occurs when the material comes into contact with 
biological surroundings (Suchanek, et al. 1998). 
Hard tissue of the human body is very important. The skeletal system provides 
support and gives shape to the body and provides a network for soft tissue attachment. 
The most common problems that are faced in hard tissues are bone fractures in addition 
to various other problems. The developments in artificial bone preparation techniques 
may solve most of the hard tissue problems. On the other hand artificial bones 
themselves may cause other problems and in many cases they do not have sufficient 
mechanical properties.  
 Ceramics, polymers, metals and composite materials are developed to be used 
as bone implants along with their advantages and disadvantages. Polymers have very 
low mechanical strength compared to bone, metals have superior mechanical properties 
but they are very corrosive, and despite their other desired properties such as wear 
resistance, biocompatibility and hardness, ceramics are brittle and have low fracture 
toughness. When all these properties of polymers, ceramics and metals are considered 
producing composite materials is a reasonable approach. 
Bone consists of 69 wt % calcium phosphate (mainly hydroxyapatite (HA)), 
21% collagen, 9%water and 1% other constituents. It has a composite nature which is 
composed of mainly ceramic and polymeric components with a complex hierarchical 
microstructure difficult to imitate which gives most of the superior mechanical 
properties to bone. Extensive research has been conducted on bone substitute composite 
materials composed of mainly hydroxyapatite and a polymer. Hydroxyapatite has 
excellent bioactivity, biocompatibility, non-toxicity and osteoconductivity properties 
but also has low toughness. Chitosan, deacetylated form of chitin, is a natural polymer 
found in vast amounts in crustaceans. It is biocompatible and 
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bioresorbable/biodegradable. It is non-toxic and easily soluble in dilute weak organic 
acids. The recent research on chitosan/hydroxyapatite composites which are partially 
biodegradable indicate that this behaviour of the composite may even be an advantage. 
New bone may intergrow around the hydroxyapatite particles when the polymer matrix 
is resorbed. Extensive research on relatively new chitosan/hydroxyapatite composites 
has been conducted recently (Zhao, et al. 2007). 
The objective of this study was the preparation and characterization of 
polymeric/ceramic porous composite biomaterials by using chitosan and hydroxyapatite 
along with also the investigation of the protein adsorption behaviour of these 
composites.  The effects of parameters such as HA and chitosan contents on BSA 
(Bovine Serum Albumin) and also HSP (Human Serum Protein) adsorption behaviour 
have been ivestigated which was considered to be a prerequiste for biocompatibility. 
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CHAPTER 2 
BIOMATERIALS AND BIOCOMPATIBILITY 
 
2.1. Biomaterials  
 
A biomaterial is defined as a non-viable material used in the production of 
medical devices and intending to interact with biological systems. Biomaterials, natural 
or synthetic in origin, can be used for any period of time or permenantly. Their function 
is to treat or replace any tissue, organ or function of the body. It is known that many 
materials have been used as potential biomaterials for surgical glues, stents, external 
fixation devices, wound dressing, and dental materials. These implants can be metallic, 
polymeric, composite or ceramic in nature. The selection of materials used for implants 
is very important with respect to their function in the body (Bosetti, et al. 2001).   
Ceramics are mainly used for the repair, reconstruction and replacement of 
diseased or damaged parts of the body especially in the mucolo-skeletal system such as 
bone. Main characteristics of ceramics for their use as biomaterials are their relatively 
high compressive strengths, biocompatibility, inertness, pore and crystalline structure 
but they are brittle and difficult to produce. Hydroxyapatite is a highly biocompatible 
ceramic which can be processed in dense or porous structure similar to natural bone. 
HA is widely used as a bone filling material and to coat the surfaces of metallic 
prosthetic implants in order to improve their biocompatibility. It has been demonstrated 
that the physical characteristics of HA particles (size, shape) could modify the toxicity 
of biomaterials in the above applications (Grandjean-Laquerriere, et al. 2004). Al2O3 (α-
alumina) is also a bioceramic widely used clinically. It is used in total hip prosthesis and 
dental implants because of its combination of excellent corrosion resistance, good 
biocompatibility, low friction, high wear resistance, and high strength (Hench 1998).  
Metals are also desired due to their mechanical properties for load bearing parts 
of body. Typical examples of highly loaded implants are hip and knee endoprothesis. In 
addition, metalic materials are also used for unloaded and functional devices such as 
heart valves (Hu, et al. 2004). Metals are known to be tough and ductile. The main 
disadvantages of these materials are poor corrossion resistance and their relatively high 
density. The release of metal ions to the body may induce biological reactions including 
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oxidative damage to lipids, proteins, and DNA because of the increase in the 
concentration of reactive oxygen species and depletion of intracellular anti-oxidants. 
They can also cause apoptosis (cell death), inflammation (initial reaction of the body 
involving redness, swelling), and mutation. With the combination of other materials or 
coating with inert materials, biocompatibility, corrosion and wear resistance can be 
improved and they can be used for a long time in the body safely (Hu, et al. 2004). The 
most frequently used metals nowadays are stainless steel (316L stainless steel) and 
titanium because of their high biocompatibility and corrosion resistance. Zinalco 
composed of 80% zinc, 18% aluminium, and 2% copper is very similar to 316L 
stainless steel and titanium due to its physical and mechanical properties. In vitro and in 
vivo test results have shown that zinalco is harmless and can be used as potential 
biomaterial (Aguilar, et al. 1999). Mechanical properties of some important biomaterials 
are given in Table 2.1. The types, advantages and disadvantages of biomaterials are 
given in Table 2.2. 
 
Table 2.1. Mechanical properties of some metallic and ceramic materials 
(Source: Ramakrishna, et al. 2001) 
 
Material Modulus (GPa) Tensile Strength (MPa) 
Stainless Steel 190 586 
Co-Cr Alloy 210 1085 
Ti Alloy 116 965 
Amalgam 30 58 
Alumina 380 300 
Zirconia 220 820 
Bioglass 35 42 
Hydroxyapatite 95 50 
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Table 2.2. Types and properties of biomaterials 
 
Materials  Advantages  Disadvantages  Examples 
Polymers  
  Nylon 
  Silicones  
 
Resilient  
Easy to fabricate  
Bioresorbable, bioinert 
 
Insufficient properties for 
load bearing applications, 
Deform with time 
May degrade  
 
Sutures, blood vessels, 
hip socket, ear, nose  
 
Metals  
  Titanium 
  Co-Cr alloys 
  Stainless steel  
 
High strength,  
tough, ductile 
 
corrosive, dense 
 
Joint replacement,  
bone plates and screws, 
dental root implants 
Ceramics  
  Alumina 
  Carbon 
  Hydroxyapatite 
 
Biocompatible, 
 inert,  
strong in compression, 
wear resistant, bioactive 
 
Brittle, 
difficult to produce,  
not resilient, high modulus 
 
Dental, hip socket 
Composites 
 
 
High strength,  
controllable mechanical 
properties and 
microstructure 
 
Difficult to produce 
 
Joint implants, heart 
valves 
 
Tissue engineering studies widely use polymeric materials with the aim of 
production of artificial organs and prothesis because of their high elasticity and 
simplicity in production. Poly (3-hydroxybutyric acid-co-3-hydroxyvaleric acid) 
(PHBV) is a natural polyester polymerized by the bacteria. This polyester is 
biodegradable and biocompatible.  PHBV can be used for biomedical applications 
including surgical sutures, wound dressings, vascular grafts, and scaffols for new tissue 
in growth (Hu, et al. 2004). Chitosan is the deacetylated derivative of chitin and one of 
the most abundant natural polysaccharides. It has been identified as hydrophilic, non-
toxic, biodegradable, and antibacterial. It has been used as wound dressing accelerator 
and immune system stimulant. Cyanoacrylates are also polymers used in the production 
of medical devices that have several advantages: they are easy and rapid to be applied, 
relatively painless and they eliminate the need for suture removal. Poly (vinyl-
pyrolidone) has interesting properties as well: immediate pain control, easy 
replacement, transparancy to allow healing follow up, and barrier against bacteria. 
Polyurethane and silicone are also most common polymers for implants such as stents 
and catheters. 
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There are many efforts to improve physical and mechanical properties of 
biocompatible materials. Composites are materials composed of two or more distinct 
materials in order to obtain stronger, tougher, more durable and biocompatible 
materials. Risbud, et al. (2001) have studied the biocompatibility of poly (butylene 
terephthalate)/wollastonite composite which is a biodegradable engineering plastic 
exhibiting bone-bonding properties, titanium implant coating, and dental implant 
applications. Wollastonite is a naturally occurring calcium silicate and it is known to be 
bioactive. Wollastonite has been reported to enhance the mechanical performance of 
composites. The difficulties in production of composites are the main drawback of these 
materials.                 
Polymer–ceramic composite scaffolds such as chitosan-hydroxyapatite 
composites are excpected to mimic natural bone. The hydroxyapatite–chitosan–alginate 
porous network has been also reported and demonstrated to be suitable for bone tissue 
engineering applications using osteoblast cells (Manjubala, et al. 2006). 
 
2.2. Biocompatibility 
 
The materials used in devices must be safe in addition to being effective. This 
characteristic or property of a material is termed as biocompatibility. Biocompatibility 
may generally be regarded as the ability of a material to interact with living cells/tissues 
or a living system by not being toxic, injurious, or causing immunological reactions 
while performing or functioning appropriately. The spectrum of biomaterials used in 
medical applications is quite broad. They range from cotton pads that stop bleeding of 
minor cuts within a few minutes; to catheters, dialysis tubes, contact lenses designed to 
interact with tissues from a few hours to weeks. They range from sutures designed to 
slowly resorb over a few weeks to months; to implant devices like total replacement 
hips and heart valves intended to last 10–15+ years or the lifetime of the patient. To 
encompass this diversity of materials and applications, a consensus panel of experts has 
defined biocompatibility as “the ability of a material to perform with an appropriate host 
response in a specific application” (Pariente, et al. 1998). This definition thus accounts 
for not only the variety of applications of materials in medical devices, but also for the 
responses of both host tissues to material and material to host tissues.  
 8
The determination of the biocompatibility of materials and implant devices 
involves detailed characterization of the material (e.g., bulk and surface chemical 
composition; density; porosity; and mechanical, electrical, and degradation properties) 
and extensive testing, first at the protein/cell/tissue or in-vitro level, and then in in-vivo 
animal models and ultimately in human clinical trials. In-vitro tests are used to screen 
materials, their components, and or leachable/soluble/degradation products for 
cytotoxic, genotoxic, immunological, and hemolytic effects. Animal models are used to 
evaluate material–host tissue interactions and to predict how the device or prototype 
may perform in humans. Ultimately, the safety and effectiveness of the device must be 
evaluated in humans prior to widespread use by physicians and their patients. At each 
stage, biocompatibility testing results must be correlated with materials properties and 
with manufacturing, sterilization, packaging, storage, and other handling procedures 
that also may influence test outcomes. 
The design and use of biocompatibility testing protocols are provided by a 
variety of professional and regulatory organizations including ASTM (American 
Society for Testing and Materials International), ISO (International Standards 
Organization), ADA ( American Dental Association), NIH (National Institutes of 
Health), and FDA (Food and Drug Administration). The use and documentation of 
biocompatibility tests are required by law in the United States and other countries, and 
are used to ensure that biomedical devices and their constituent materials are safe and 
effective under intended application conditions.  
 
2.3. Bone 
 
2.3.1 Structure and Composition of the Bone 
 
Bone is a specialized connective tissue with mineralized extracellular matrix 
(ECM). Bone grafting is routinely performed to restore bone loss due to trauma or 
disease. Although autogenous cancellous bone is considered to be the gold standard for 
bone grafts, there are several limitations, including inadequate availability, increased 
operative blood loss from the two-site surgery, and potential donor-site morbidity. 
Allogeneic grafts are also problematic due to risks in infection, allograft fracture, 
pathogen transmission, and immune rejection. It has, therefore, become necessary to 
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find suitable alternatives, particularly when a large graft is required. Bone tissue 
engineering is a promising alternative to bone grafting. In the tissue engineering 
approach, the following components are generally required: cells that can differentiate 
into osteoblasts, an artificial extracellular matrix (ECM; i.e., scaffold), and regulating 
bioactive molecules that promote cell recruitment, growth, differentiation, and 
mineralized bone tissue formation (Zhang, et al. 2001). These components have to be in 
concert with each other to achieve optimal tissue regeneration.  
The extracellular matrices (ECMs) of hard tissues are composed of organic and 
inorganic phases, the inorganic phase consisting primarily of HA crystals, and the 
organic phase consisting mainly of type I collagen and small amounts of other substance 
including glycosaminoglycans (GAGs), proteoglycans and glycoproteins. 
 
Table 2.3. The composition of the bone 
(Source: Park, et al. 1992) 
 
Component Amount (wt %) 
Hydroxyapatite 69% 
Organic matrix 
• Collagen 
• Others 
22% 
90-96% of organic matrix 
4-10% of organic matrix 
Water 9% 
 
Bone is difficult to analyze because it has so many levels of organization. The 
main constituents of bone are collagen (21 wt. %), calcium phosphate (69 wt. %) as 
given in Table 2.3. Additionally, water and other organic materials such as proteins, 
polysaccharides and lipids are also present in small quantities. Collagen which can be 
considered as the matrix is in the form of small microfibers. It is difficult to observe 
distinct collagen fibers because of its net-like mass appearence. The diameter of 
collagen microfiber varies from 100 to 2000nm (Suchanek, et al. 1998). The 
hydroxyapatite crystals are present in the form of plates or needles which are about 40-
60 nm long, 20 nm wide and 1.5-5 nm thick. They are arranged parallel to the collagen 
fibers, such that the larger dimension of crystals axis along the axis of fiber.There is a 
hierarchical structure which can be seen in Figure 2.1. (Park, et al. 1992). 
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Figure 2.1. Organisation of Bone (a) Compact and Cancellous (b) Compact  
(Source: Park, et al. 1992) 
 
Bone consists of two main parts, compact bone, also known as cortical bone, and 
the cancellous bone, also known as trabecular or spongy bone. Compact bone is the 
outer surface of the human bone. It is harder and denser compared to the spongy bone. 
Cancellous bone is softer and has lower density compared to the compact bone. The 
mineral-containing fibers are arranged into lamellar sheets (3-7 μm thick) 4-20 lamelae, 
which are arranged in concentric rings around the Harversian Canal, form an osteon 
(Suchanek, et al. 1998). 
The metabolic substances can be transported by the intercommunicating systems 
of canaliculi, lacunae, and Volkman’s canals, which are connected with the narrow 
cavity. The various interconnecting systems are filled with body fluids and their volume 
can be as high as 19% (Suchanek, et al. 1998). 
Due to the properties mentioned, there is not a homogeneous composition and all 
the properties/compositions are directionally and regionally dependent. 
 
2.3.2. Mechanical Properties of Bone 
 
Bones of the skeletal system provide the supporting structure for the body. The 
low elastic modulus collagen fibers are aligned in bone along the main stress direction. 
The high elastic modulus hydroxyapatite mineral includes approximately 70 % of the 
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dry bone mass and contributes significantly to the bone stiffness. Bone can remodel and 
adapt itself to the applied mechanical environment, which is generally known as 
Wolff’s Law which is the principle relating the internal structure and architecture of the 
bone to external mechanical stimuli. Remodeling of bone takes place in response to 
mechanical stimulation so that the new structure becomes suitably adapted to the load. 
Density of living bone is influenced by the stress condition applied to the bone. Higher 
applied stress leads to the denser bone, conversely if the applied stress is lower than the 
normal physiological load, the bone mass decreases and leads to bone weakening. Bone 
is an anisotropic material as longitudinal mechanical properties of cortical bone are 
higher than the transverse direction properties. Bone is generally weak in tension and 
shear, particularly along the longitudonal plane (Ramakrishna, et al. 2001). 
 
 
 
Figure 2.2. Stress as a function of strain and strain rate for human compact bone  
(Source: Park, et al. 1992) 
 
Bone exhibits excellent toughness (at low strain rates) mostly due to its 
hierarchical structure, which stops cracks after a little propagation. The main 
toughening mechanism seems to be microcracks, which appear in the plastic region of 
the stress-strain curve. The stress strain curves of bone due to changing strain rates are 
given in Figure 2.2. (Park, et al. 1992). 
The mechanical properties of bone depend largely on the humidity, mode of 
applied load, direction of the applied load, and the kind of bone. With increasing level 
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of bone mineralization, strength increases. Moreover, strength and other mechanical 
properties of bone depend on orientation of the collagen fibers, bone density, and 
porosity, molecular structure and arrangement of its constituent apatite crystals within 
their collagen matrix (Suchanek, et al. 1998). Both strength and volume of human bone 
decrease dramatically with age. 
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CHAPTER 3 
 
CHITOSAN / HYDROXYAPATITE COMPOSITES 
 
3.1. Chitosan 
 
Chitosan as a natural biopolymer, is a potential candidate for tissue engineering 
and drug delivery systems. It is one of the most abundant naturally occurring 
polysaccharides, primarily obtained as a sub-product of seafood, containing amino and 
hydroxyl groups. The primary unit of chitin is 2-acetamido–2-deoxy-D-glucose, while 
that of chitosan is 2-amino-2-deoxy-D-glucose with β→1-4 glucosidic linkages.  In 
Figure 3.1. the sructures of chitin and chitosan are shown. Generally, chitin is obtained 
from crustaceans or mollusks and as mentioned before chitosan is prepared from its N-
deacetylation. 
 
                              
Figure 3.1. Structure of chitin and chitosan 
 
Chitosan is insoluble in water, alkali and many organic solvents but soluble in 
many dilute aqueous solutions of organic acids, of which most commonly used are 
formic acid and acetic acid. Apart from being bioresorbable it is biocompatible, non-
toxic, non-antigenic and biofunctional (Zhang, et al. 2001). Chitosan has been proposed 
to serve as a non-protein matrix for 3D tissue growth. Chitosan could provide the 
biological primer for cell-tissue proliferation and reconstruction. One of the most 
promising features of chitosan is its excellent ability to be processed into porous 
structures for use in cell transplantation and tissue regeneration. In tissue engineering, 
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the porous structure of chitosan provides a scaffold for bone cells to grow in and seed 
new bone regeneration. For rapid cell growth, the scaffold must have optimal micro 
architecture such as pore size, shape and specific surface area. Therefore the major goal 
in fabricating scaffolds for bone tissue engineering is to accurately control pore size and 
porosity. Porous chitosan structures can be formed by freezing and lyophilising 
chitosan–acetic acid solutions in suitable moulds. Pore orientation can be directed by 
controlling the geometry of thermal gradients during freezing. The use of chitosan 
scaffolds in tissue engineering has been reported and a porous chitosan matrix has been 
suggested as a potential candidate for bone regeneration due to its biological and 
physical properties. 
Under acidic conditions, chitosan in its original form adopts a positive charge 
which can attract negatively charged plasma proteins leading to platelet adhesion and 
activation followed by thrombus formation and blood coagulation This sequential 
response should partly be responsible for the success of chitosan in wound healing 
acceleration. Antimicrobial activity is believed to originate from the ability of cationic 
species to bind with sialic acid in phospholipids, consequently restraining the movement 
of microbiological substances. Oligomeric chitosan can also penetrate into the cells of 
micro-organisms and prevent the growth of cells by prohibiting the transformation DNA 
into RNA (Manjubala, et al. 2006). 
 
3.2. Hydroxyapatite  
 
Pure HA [Ca10 (PO4)6 (OH)2] has the theoretical composition of: 39.68 wt % Ca, 
18.45 wt % P, Ca/P weight ratio of 2.151 and Ca/P molar ratio of 1.67 (Hench, et al. 
1993). 
  The term apatite describes a family of compounds having similar structures but 
not necessarily having identical compositions. Apatite is a description not a 
composition. Hydroxyapatite also named as calcium hydroxyapatite has a definite 
composition and a crystallographic structure. Hydroxyapatite belongs to the hexagonal 
system, with a space group, P63/m. This space group is characterized by a six-fold c-
axis perpendicular to three equivalent a-axes (a1, a2, a3) at angles 120o to each other. 
Unit cell consists of Ca, PO4, and OH groups closely packed together (Hench, et al. 
1993). Figure 3.2. represents the crystal structure of hydroxyapatite. 
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Figure 3.2. Schematic of crystal structure of hydroxyapatite (hexagonal) 
 
From the point of view of biocompatibility, hydroxyapatite seems to be the most 
suitable ceramic material for the hard tissue replacement implants since hydroxyapatite 
is the main mineral constituent of teeth and bones. Hydroxyapatite ceramics do not have 
any toxic effects. They show excellent biocompatibility with hard tissues and also with 
skin and muscle tissues and HA can directly bond to bone. Unfortunately due to the low 
reliability, especially in wet environments the HA ceramics cannot presently be used for 
heavy load bearing applications, like artificial teeth or bones. There has been extensive 
research towards increasing the mechanical reliability of HA. 
 
3.3. Chitosan / Hydroxyapatite Composites 
 
As a consequence of tumors, infections, trauma, or other causes, bone defects 
need to be repaired. An ideal clinical bone substitute material should be nontoxic, 
biocompatible with all the tissues, including bone and blood, around it, and 
osteoconductive to form a good environment in the interface of mature bone and the 
implant, and maintain good mechanical properties in the wet state (Zhao, et al. 2007). 
The research on chitosan/HA composite biomaterials for hard tissue applications 
has been conducted for the last 5 years whereas other bioresorbable composite materials  
have been in clinical use for about 15 years which is also a relatively short time. This is 
a promising area beause use of bioresorbable polymer ceramic composites have many 
advantages. The main drawback of such materials is insufficient mechanical properties 
compared to bone.  
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Hydroxyapatite (HA) based materials, having a similar chemical composition to 
that of the mineral phase of bone, are excellent candidates for bone repair and 
regeneration and have been used in bone tissue engineering for the last two decades. 
Though HA (Ca10(PO4)6(OH)2) is bioactive and osteoconductive, its mechanical 
properties are inadequate, making it unable to be used as a load bearing implant (Park, 
et al. 1992). In order to achieve controlled bioactivity and biodegradability, polymer–
ceramic composites have been proposed. Polymers such as chitosan have a higher 
degradation rate than bioceramics. Incorporation of HA into a chitosan polymer matrix 
has also been shown to increase osteoconductivity and biodegradability with significant 
enhancement of mechanical strength (Park, et al. 1992). To combine the 
osteoconductivity of calcium phosphate and good biodegradability of polymers, 
composites have been developed for bone tissue engineering (Suchanek, et al. 1998). 
Polymer–ceramic composite scaffolds are expected to mimic natural bone, in the way 
that natural bone is also a composite of inorganic compounds (calcium phosphates 
especially substituted carbonated hydroxyapatite) and organic compounds (collagen, 
protein matrix, etc.), (Manjubala, et al. 2006). 
3.3.1. Processing of Chitosan / Hydroxyapatite Composites 
  
The preparation and characterization of chitosan/HA composites to be used as 
hard tissue implants have been investigated in the literature. There are several 
preparation techniques for chitosan/HA composites. Commonly used methods are phase 
separation (freeze drying), precipitation, sol-gel and using bone cement formulations. 
 Zhao, et al. (2007) investigated the preparation of three dimensional 
hydroxyapatite/chitosan-gelatin network composite scaffolds produced by phase 
separation method. A suspension was prepared by using pulverized hydroxyapatite and 
deionized distilled water. After 0.5 h stirring at room temperature the suspension was 
treated ultrasonically until the HA powder was thoroughly dispersed in the water. 
Chitosan and acetic acid were added under agitation. After stirring overnight gelatin 
was added to this suspension which was held in 40oC water bath. After addition of a 
glutaraldehyde solution the mixture was put into plastic petri dishes at 4oC half an hour 
then rapidly transferred to a freezer at –40oC to solidify the solvent and induce solid-
liquid phase separation. Solidified mixture was maintained at that temperature for 2 
hours and placed in a freeze-drier. The sample was finally freeze-dried for at least 30h 
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and the prepared foam were cut into discs. Changing the HA content and the 
compositional variables of the original suspension allowed control of the porosities and 
densities of the scaffold as tabulated in Table 3.1.  
 
Table 3.1. The porosities and densities of the prepared CS-Gel/HA scaffolds 
(Source: Zhao, et al. 2007) 
 
CS-Gel 
concentration
(w/v)% 
CS-Gel/HA 
Ratio (w/w)% 
Quenching 
Temperature 
(oC) 
Density 
(kg/m3) 
 
Porosity (%)
1.0 50/50 -20 0.042±0.017 95.8±8.3 
2.5 50/50 -20 0.083±0.09 93.4±11.5 
5.0 50/50 -20 0.156±0.011 90.6±6.8 
7.5 50/50 -20 0.237±0.05 85.2±3.9 
2.5 70/30 -20 0.078±0.010 94.7±8.7 
2.5 30/70 -20 0.091±0.013 91.0±7.2 
2.5 50/50 -80 0.092±0.011 91.8±5.9 
 
In another study by Ang et al., three dimensional chitosan-hydroxyapatite 
scaffolds were prepared by using a robotic dispensing system. The dispensing material 
was prepared by dissolving chitosan in acetic acid and adding HA to obtain different 
HA/chitosan ratios to form a hydrogel. The mixture was stirred for 2h and transferred to 
a vacuum oven (preset at 37oC) to remove air bubbles. By using the robotic dispensing 
machine the dispensing materials were extruded into a dispensing medium. The 
extruded 3D scaffolds were immersed in ethanol for 5 min and washed 3 times with 
distilled water. The scaffolds were then rapidly transferred to a freezer at –20 oC to 
solidify solvent so as to induce a solid liquid phase separation. The frozen scaffolds 
were maintained at –20 oC for at least 8h and then freeze dried at –56 oC for 2 days to 
remove the solvent. In vitro cell culture study was performed for biocompatibility 
characterization. 
Zhang, et al. (2001) prepared chitosan scaffolds reinforced by calcium 
phosphates by phase separation method. Chitosan solutions with concentration of 2 wt% 
were prepared by dissolution of chitosan in acetic acid solution. The mixture was stirred 
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at 50 oC for 2h to obtain a homogeneous polymer solution. Calcium phosphate invert 
glass and β-TCP powders were added into the solution. The final composition of the 
composite foam was determined by the concentration of the chitosan solution and 
calcium phosphate content in the mixture. The mixture was then rapidly transferred into 
a freezer (–20 oC) to solidify the solvent and induce solid liquid phase separation. The 
solidified mixture was maintained at that temperature for 8h and the frozen mixture was 
then transferred into a freeze-drier at –5 oC preset temperature. The samples were freeze 
dried at 0.5 mmHg for at least 4 days to completely remove the solvent. In their study 
the effect of the chitosan content on mechanical properties, physical properties and in 
vitro observation was investigated.  
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CHAPTER 4 
 
ADSORPTION 
 
 4.1. Adsorption, Adsorptive, Adsorbent  
 
Adsorption is the adhesion of molecules on the surfaces of solids. Adsorption 
was defined as the enrichment of one or more components in an interfacial layer. Solid 
material on which solutes of interest adhere is called as the adsorbent. The material in 
the fluid phase which is capable of being adsorbed is called the adsorptive. The material 
adsorbed on the solid is called as the adsorbate.   
When the mixture to be separated is brought into contact with another insoluble 
phase, the adsorbent, an unequal distribution of the original constituents between the 
adsorbed phase on the solid surface and the bulk of the fluid occur which permits 
separation. The adsorption often occurs as a monolayer on the surface of the adsorbent. 
However, several layers sometimes occurs.  
There are two types of adsorption phenomena: physical and chemical 
adsorption. Characteristic features of physical and chemical adsorption are shown in 
Table 4.1.  
Physical adsorption is a reversible phenomena which is a result of inter 
molecular forces of attraction between molecules of solid and adsorbate. These forces 
involved in physical adsorption include both Van der Waals forces (dispersion- 
repulsion) and electrostatic interactions comprising polarisation, dipole and quadropole 
interactons. In the case of some adsorbents with an ionic structure, besides Van der 
Waals forces, electrostatic interactions are also significant. 
Chemisorption is the result of the chemical interactions between the adsorbent 
and the adsorbate. The strength of the chemical bond may vary considerably. The force 
of adhession is usually much grater than that found in physical adsorption. 
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Table 4.1. Characteristic features of physical and chemical adsorption 
 
 
Desorption is opposite of adsorption and the amount adsorbed decreases if the 
difussion is in the opposite direction, mass transfer from adsorbent to the fluid phase, 
desorption takes place. When the reverse isotherm does not follow the same path of 
adsorption, adsorption hysteresis evolves.  
Adsorbents must posses certain engineering properties depending upon the 
application. Many adsorbents have been devoleped for a wide range of separations. 
Typically, adsorbents are in the form of small pellets, beats, or granules ranging from 
about 0.1 mm to 12 mm in sizes. The performence of an adsorption process depends 
heavily on the capacity of the adsorbent. 
Physical adsorption Chemical adsorption 
Low heat of  adsorption 
(<2 or 3 times latent heat of evaporation)
Non specific 
Monolayer or multilayer 
No dissociation of adsorbed species. 
Only significant at relatively low 
temperatures 
Rapid  
Non activated 
Reversible  
No electron transfer although 
polarization of adsorbate may occur. 
High heat of  adsorption 
(>2 or 3 times latent heat of evaporation)
Highly specific 
Only monolayer 
May involve dissociation possible over a 
wide range of temperatures 
 
Slow  
Activated  
İrreversible  
Electron transfer leading to bond 
formation between adsorbate and 
surface  
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Adsorbents must have large surface area. The amount they adsorb is roughly 
proportional to the surface area of the adsorbent which nessecitates the condition that 
they must have porous structures. Pore sizes and total pore volume of adsorbents are 
very important as well as shape of the pores.  
The following classification of pores according to width have been commonly 
adopted in the literature: 
• Macropores (>50 nm) 
• Mesopores (2-50nm) 
• Micropores (<2nm) 
In addition to these properties, the usefullness of an adsorbent is a function of 
the composition, hydrophilicity-hydrophobicity, the nature of present ligands or other 
functional groups, the mechanical and chemical stability of the adsorbent. The 
adsorbents used in bioprocesses should also be biocompatible, resistant to 
microorganisms, sterilizable, and stable. 
Different adsorbents utilize different bonding mechanisms. Adsorbents can be 
classified in three main groups as inorganic (silica, carbon, calsium phosphate, zeolites, 
etc.), synthetic polymers or resins (dextran, poysulfone, etc.), and composites (silica-
dextran, hydroxyapatite-chitosan, etc.). 
             Inorganic adsorbents such as activated carbon, silica and alumina are generally 
rigid, stable and available in many sizes and shapes. The selectivity however is rather 
low, regeneration is also difficult and the life time is limited. Activated carbon has non 
polar surfaces that are used to adsorb nonpolar molecules especially hydrocarbons. 
Activated alumina which has a polar surface is largely used as a dessicant. HA is used 
for proein purification.  
The most important class of inorganic adsorbents is probably zeolites, a subclass 
of moleculer sieves. They are crystalline aluminasilicates with specific pore sizes 
located within small crystals. 
Synthetic polymers are prepared by polymerizing monomers. They are avaiable 
in a gel and macroreticular sponge like structure. They are used in a wide range of 
applications such as in the recovery of antibiotics and adsorbing organic and inorganic 
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pigments etc. Their mechanical strength, especially that of gel type limits their 
applicability in large scale processes and they are mainly used in chromotography.  
The composite adsorbents combine the disadvantages of the inorganic rigid 
carrier with the favourable adsoption behavior of polymeric adsorbents. The inner 
surface of an inorganic carrier is covered with a very thin layer of an organic material. 
Composite adsorbents can be applied in the recovery of proteins. 
 
4.2. Adsorption Equilibra 
 
The analysis of adsorption is based on equilibria and on mass balance. The 
equilibria are presented as adsorption isotherms at constant temperature. The amount 
adsorbed varies with concentration. This relation betwen the amount adsorbed on the 
solid and concentration in the fluid is called as an isotherm. 
Typical isotherms for various materials for liquid adsorption are shown in Figure 
4.1. 
      
                                  Figure 4.1. Common adsorption isotherms 
 
For each isotherm, the abcissa gives the solute concentration in the solution in 
units of mass of solute per volume of solution. The ordinate gives the solute 
concentration on the surface of the adsorbent most commonly in units of mass of solute 
per mass of adsorbent. Any isotherm with a downward curvature is referred to as 
favorable and any isotherm with an upward curvature is referred to as unfavourable. 
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Langmuir (good theory) 
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The determination of adsorbtion isotherm is important in providing data such as 
maximum capacity of adsorbent and dissociation constant. The linear isotherm can be 
expressed by an equation similiar to Henry’s law: 
cKq .=                                                                (1) 
where q is the amount of solute adsorbed per amount of adsorbent, c is the solute 
concentration in solution, K is a constant determined experimentally in volume of 
solution per mass of adsorbent. This linear isotherm is not common but in dilute region 
it can be used to approximate data of many systems. 
 The Freundlich isotherm equation, which is empirical often approximates data 
for many physical adsorption systems and is particularly useful for liquids. 
 ncKq .=                                                               (2) 
where K and n are constants and must be determined experimentally if a log-log plot of 
q versus c is made, the slope is the dimensionless exponent n. The dimensions of K 
depend on the value of n. 
The Langmuir isotherm has a theoretical basis and it is given by: 
 
cK
cqq m+=
.
                                                             (3) 
Where qm  and K are again constants. The dimensions of qm and K are the same as those 
of  q  and c respectively. K and qm must be determined experimentally. By plotting l/q 
versus l/c the slope gives K/ qm and the intercept is l/ qm. 
 
qm  =Maximum adsorption capacity 
q = amount adsorbed at equilibrium 
c = concentration of free adsorptive at equilibrium 
K = dissociation constant 
 
A series of asumptions are made in the theoretical formulation of the Langmuir 
isotherm. It is assumed that only a fixed number of active sites are available for 
adsorption and a monolayer is formed through reversible adsorption. There are no 
lateral interactions between adsorbate molecules and all adsorption sites are identifical 
with no changes in the structure upon adsorption. 
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4.3. Adsorption Kinetics 
 
To understand the mechanism of adsorption, it is also important to determine the 
mass transfer rates in a system. Determining the rate of adsorption is useful to know 
how fast the equilibrium phase is attained. The rate of adsorption is based on mass 
balances. 
Analysis is based on finite rates of mass tranfer and an equilibrium isotherm or 
adsorption kinetics for a certain system. 
Differences in rate theory models are mainly due to the differences in describing 
the mass transfer. Various steps (and resistances) to this mass transfer can exist: 
1. Mass transfer from the fluid phase to the external surfaces of the adsorbent 
particles ( film diffusion resistance) 
2. Pore diffusion in the fluid phase (pore diffusion resistance) 
3. Adsorption reaction at the phase boundaries ( surface reaction resistance) 
4. Diffusion in the sorbed state ( particle phase diffusion resistance). 
The rate limiting step may be one or a combination of the above mass transfer 
steps. For some adsorbents two mechanisms may occur in parallel and the faster 
controls the rate of adsorption. Each step involves a different concentration driving 
force and gives rise to a somewhat different form of mathematical result. 
 In the mathematical modelling of adsorption processes an option is to model a 
system as realistically as possible taking into account the individual resistances to mass 
transfer. However, the mathematics involved can be complex and in some 
circumstances an option may be to use simplified rate equations for the liquid-solid 
interface mass transfer, essentially combining the resistances to mass transfer to give 
what are known as lumped parameter models. These simplified models are used 
especially for well-stirred vessels when adsorbtion is homogeneous. 
Experimental kinetic data are frequently analyzed with the Langmuir equation. 
The model assume that the adsorption can be taken as a reversible mass transfer process 
in which free adsorbate becomes bound to the adsorbent. The adsorption proceeds at a 
rate proportional to the product of the concentration of adsorbate in solution and the 
concentration of unused adsorbent. The reverse rate is proportional to the amount of 
adsorbate bound to the adsorbent. The rate equation describing the process can be 
written as: 
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( ) qKqqcK
dt
dq
dma −−=                                                 (4) 
where c is the concentration of the adsorbate in solution and q is the concentration of 
adsorbate adsorbed on adsorbent. Ka and Kd are the forward and reverse rate 
coefficients and qm is the maximum capacity of the adsorbent. da KKK /=  is the 
dissociation constat. Ka and Kd include contributions from the individual resistances to 
mass transfer from the bulk of the mobile phase to the available sites on the adsorption 
media. Ka , Kd and qm  can be determined from equilibrium and mass transfer rate 
experiments. Adsorption equilibrium is attained when 0/ =dtdq  and 
 ( ) qKqqcK dma =−                                                        (5) 
from this equality  
cK
cq
q m+=  , where K is the dissociation constant. 
 
4.4. Batch Adsorption 
 
Batch adsorption is often used to adsorb solutes from liquid solutions when the 
quantities treated are small. An equilibrium relation such as Freundlich or Langmuir 
isotherm and a mass balance are needed. Initial feed concentration( c0 ) and the final 
equilibrium concentration (c).  q and qo are the final and initial concentrations on the 
adsorbent. Ws is the amount of adsorbent and V is the volume of feed solution. 
qWcVWqVc s +=+ 00                                                       (6) 
This equation can be rearranged: 
( )cc
W
Vqq
s
−+= 00                                                           (7) 
If q is plotted against c according to the above equation, the result is a straight line. If 
the equilibrium isotherm is also plotted on the same graph, the intersection of both Iines 
gives the final equilibrium values of q and c.  
When batch adsorption takes place in a well stirred vessel, concentration of the 
fluid in the vessel decreases with the progress of the process. In this case, the mass 
balance in the vessel will be expressed in the following form when q0= 0 is cosidered at 
t=0. 
( )cc
W
Vq
s
−= 0                                                            (8) 
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q can be calculated from the above equation. In the liquid phase adsorption, it is 
difficult to follow directly the change of amount adsorbed but the progress of adsorption 
may be traced by observing the concentration changes in the liquid phase as a function 
of time. 
 
4.5. Protein Adsorption 
 
Before protein adsorption behavior can be understood, it is first important to 
understand the basic makeup of protein structure. Proteins are complex copolymers that 
are made up of four levels of structure, designated as the primary, secondary, tertiary, 
and quaternary structures. The primary structure involves the specific sequence of the 
20 L-amino acids coded for by the DNA of a cell. As part of a protein, a given amino 
acid is referred to as a peptide residue. Each amino acid, or residue, has the general 
backbone structure of f–NH– CaHR–CO–g, with R designating a specific side-group 
structure that gives the residue its specific functional characteristics. Accordingly, the 
amino acids are subcategorized into three primary types: nonpolar (i.e., hydrophobic),   
-charged, and polar. Examples of each type of amino acid are shown in Figure 4.2.  
(Latour 2005). 
In the past decade, the researchers have conducted fundamental studies of the 
adsorption of acidic BSA, neutral MGB, and basic LSZ onto various kinds of synthetic 
HAp particles (Kandori, et al. 2007). Table 4.2.  shows the properties of some proteins. 
 
Table 4.2. Properties of proteins 
(Source: Kandori, et al. 2007) 
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Figure 4.2. Protein structure 
(Source: Latour 2005) 
 
Albumin is the predominant plasma protein, making up 60–70% of plasma [20], 
yet it is not considered a mediator of acute inflammation.  Although there is evidence 
that monocytes can and do, at least in vitro, adhere to albumin-coated surfaces, albumin 
is generally considered to “passivate” the surface and greatly reduce the acute 
inflammatory response to the material.  Other constituents of plasma, despite their 
smaller numbers, must influence the adherence of phagocytic cells involved with 
inflammation (Zhoua, et al. 2007).   
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Figure 4.3. Protein Adsorption 
 (Source: Lousinian, et al. 2007) 
 
Protein adsorption has been investigated extensively during the past decades. 
This is an important aspect for the improvement of many applications, such as medical 
implants, biosensor design, etc. When biomaterials are implanted into animals or 
humans, protein adsorption onto the foreign surface occurs within seconds of 
implantation (Kandori, et al. 2007).  This rapid protein adsorption means that cells 
arriving at the biomaterial surface probably interact with the adsorbed protein layer 
rather than directly with the material itself.  Thus, the initial protein adsorption onto a 
biomaterial surface plays a key role in how the body responds to an implanted 
biomaterial. Protein adsorption onto solid surface is given in Figure 4.3. (Lousinian, et 
al. 2007). 
The density, orientation, and conformation of surface-bound proteins are believed to 
be key factors in controlling subsequent cellular adhesion (Lousinian, et al. 2007). 
 
4.6. BSA Adsorption onto Chitosan, HA and Chitosan/ HA 
Composite  Scaffolds 
 
Protein adsorption characteristics of calcium hydroxyapatite modified with 
pyrophosphoric acids (PPa) were examined by Kandori, et al. (2007) The amounts of 
proteins adsorbed on the PP-Hap particles were measured by a batch method. This 
measurement was conducted at 15 ◦C employing a 1×10−4 mol/dm3 KCl solution of the 
protein in 10 cm3 Nalgen polypropylene centrifugation tubes. The centrifugation tubes 
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were gently rotated end-over-end at 15 ◦C for 48 h in a thermostat. The amounts of 
adsorbed protein were measured by the microbiuret method using an UV absorption 
band at 310 nm after centrifuging the dispersions. Most of the UV experiments were 
triplicated and reproducible within 2%, indicating an uncertainty of 2×10−2 mg/m2 for 
the amounts of protein adsorbed. 
 
                                
 
 
Figure 4.4.  Adsorption isotherms of proteins. [PPa] mmol/dm3  (o) unmodified, (◊) 2,   
(Δ) 4,and (͗) 6 
                     (Source:  Kandori,  et al. 2007) 
 
 The PPa modified HA particles (abbreviated as PP-HA) possessed anchored 
polyphosphate branches on their surfaces. The proteins of bovine serum albumin (BSA), 
myoglobin (MGB), and lysozyme (LSZ) were examined. The saturated amounts of 
adsorbed BSA were increased three-fold by the surface modification with PPa though 
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they were independent of the [PPa] as shown in Figure 4.4. This remarkable adsorption 
enhancement was explained by a three-dimensional binding mechanism. The anchored 
structure of the PP-branches developed on the HA surface to provide three-dimensional 
protein adsorption spaces was proved by a comparative experiment that was elucidating 
the effect of pyrophosphate ions for BSA adsorption onto HA. 
 Zhao, et al. (2007) fabricated two types of biomimetic composite materials, 
chitosan–gelatin (CG) and hydroxyapatite/chitosan–gelatin (HCG), and compared the 
effects of HA on human mesenchymal stem cell (hMSC) adhesion and 3-D construct 
development. Morphology of these composite materials are in Figure 4.5. The 2-D 
membranes were prepared to examine the influence of HA on adhesion efficiency of 
hMSCs,  3-D porous scaffolds were produced to investigate the effects of HA on 
material adsorption properties and 3-D hMSC construct development. 
  
  
 
Figure 4.5. Morphology of the HCG (a) and CG (b) scaffolds 
(Source: Zhao, et al. 2007) 
 
After composite scaffolds were prepared by freeze-drying method, the 3-D 
porous HCG and CG scaffolds were treated with 50ml NaOH solution (10%) in 50ml 
ethanol followed by repeated washing with DI H2O. The samples were put back into the 
freezer at -25 0C for 3 h and freeze-dried again in the lyophilizer at  -60 0C for 12 h. The 
samples were weighed and then put into complete media for a predetermined time. The 
samples were taken out and washed with PBS three times for 5 min each, and then they 
were put back into the freezer at -25 0C for 3 h and freeze-dried again in the lyophilizer 
at -60 0C for 12 h. The samples were weighed and their weight changes were calculated 
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as average percentage increases of three samples. The media was changed every 3 days. 
The concentration of Ca2+ in the media was measured by Varian Spectra AA–640 Flame 
Atomic Absorption Spectrophotometer (FAAS). The concentration of the proteins in the 
media was quantified with a commercial protein assay kit (Bio-Rad Laboratories, 
Hercules, CA), using bovine serum albumin (BSA) standards. The concentrations of 
proteins and Ca2+ were the averages from three wells. The adsorbed calcium and 
proteins on the 3-D porous scaffolds were determined by subtracting the amount of 
calcium or proteins left in the media after adsorption from the amount of calcium or 
proteins in control media (without specimen) under the same incubation conditions. 
The accumulated weights of proteins and calcium (Figure 4.6.) adsorbed on the 
3-D porous scaffolds calculated from the concentration changes of proteins and Ca2+ in 
the media also revealed the adsorption characteristics of the materials. The adsorbed 
proteins and calcium increased with time on both 3-D HCG and CG scaffolds, and 
higher protein amount were detected in HCG, suggesting that the incorporation of HA 
in the scaffolds enhanced the protein and calcium adsorption capability of the scaffolds. 
 
 
 
Figure 4.6.  Absorption characteristics of 3-D HCG and CG scaffolds incubated in the 
complete media with 10% FBS as a function of time. (b) proteins 
adsorption on HCG and CG scaffolds; (c) calcium adsorption on HCG and 
CG scaffolds 
                    (Source: Zhao, et al. 2007) 
 
Figure 4.7. shows that the cells cultured in 3-D porous HCG scaffolds maintain 
significantly higher CFU-F numbers than the cells cultured in 3-D porous CG scaffolds 
during 35-day culture period, suggesting that hMSCs maintained higher differentiation 
potential in the HCG scaffolds. 
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Figure 4.7.  CFU-F levels of hMSCs cultured in HCG and CG scaffolds over a 35-day         
culture period 
                     (Source: Zhao, et al. 2007) 
 
In this study, HA was found to promote protein and calcium ion adsorption of 
the 3-D porous scaffolds in the complete tissue culture media. HMSCs exhibited higher 
initial cell adhesion efficiency to 2-D HCG membranes, and maintained higher 
proliferation rates in the 3-D porous HCG than CG scaffolds with 3.3 times higher final 
DNA amount in HCG scaffolds over a 35-day period. The results demonstrate that 
enhanced protein and calcium ion adsorption properties of HA in the CG polymer 
network improve initial cell adhesion and long-term growth, favor osteogenic 
differentiation upon induction, as well as maintain the progenicity of the 3-D hMSC 
constructs. 
The adsorption characteristics of BSA onto the magnetic chitosan nanoparticles 
have been investigated by Wang, et al. (2001). They prepared the magnetic chitosan 
nanoparticles by adding the basic precipitant of NaOH solution into a W/O 
microemulsion system and observed the morphology of magnetic chitosan nanoparticles 
by transmission electron microscope (TEM). They found that the diameter of magnetic 
chitosan nanoparticles was from 10 nm to 20 nm, and the nanoparticles suspending in 
the aqueous solution could easily aggregate by a magnet, which suggested that the 
nanoparticles had good magnetic characteristics.  
Three milligrams of magnetic chitosan nanoparticles and 3 ml of BSA buffer 
phosphate acid solution were added into a 5 ml of centrifugal tube, the mixture was 
stirred for 30 min, the nanoparticles were precipitated with centrifugation (10,000 rpm 
for 7 min). The upper clear liquid was obtained and the BSA concentration was 
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measured with the Folin method. Changing the initial BSA concentration and pH of 
BSA solution, the equilibrium was investigated. When the adsorption kinetics was 
measured, 10 µL of samples were taken every certain time. The adsorption capacity 
under different pH was investigated. Under the comprehensive function of many 
factors, the highest adsorption capacity of BSA is achieved at pH=4. The adsorption 
loading reaches the maximum 110 mg/g when the pH of solution is equal to 4. Because 
the diameter of magnetic chitosan nanoparticles is between 10 and 20 nm, and then the 
composite nanoparticles have larger surface-to-volume ratios, more functional groups 
are exposed. So the magnetic chitosan nanoparticles have larger capacity. 
Using 3 mg of magnetic chitosan nanoparticles adsorbed 3 ml of BSA solution 
with initial concentration of 300 mg/l, the adsorption kinetics is studied. Since the 
nanoparticle has very small diameter and great surface-to-volume ratio, it can quickly 
reach the adsorption equilibrium. Within 10 min it achieved the adsorption equilibrium. 
 
                       
 
Figure 4.8.  Comparison of the adsorption loading of chitosan nanoparticles, Fe3O4    
nanoparticles and the composite nanoparticles 
         (Source: Wang, et al. 2001) 
 
Figure 4.8. shows the adsorption capacity of chitosan nanoparticles, magnetic 
chitosan nanoparticles and Fe3O4 nanoparticles. It was found that the adsorption 
capacity of composite chitosan nanoparticles was a little higher than that of pure 
chitosan, this is because the Fe3O4 is also available to adsorb many BSA, the NH2 group 
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of BSA molecule can bind with the orbit of  Fe atom, the capacity of Fe3O4 
nanoparticles which was obtained by calcining the composite nanoparticles to remove 
the chitosan was higher than that of  pure chitosan nanoparticles. 
In this study, the BSA adsorption experiment indicated that when pH of BSA 
solution was equal to 4, the maximum adsorption loading reached 110 mg/g. Through 
measuring the zeta potential of BSA solution and the magnetic nanoparticles, it was 
found that under this situation the surface of BSA took the negative charge, but the 
magnetic nanoparticles took the positive charge. Due to the small diameter, the 
adsorption equilibrium of BSA onto the nanoparticles reached very quickly within 10 
min. The experimental results showed that the magnetic chitosan nanoparticles have 
potential to be used for the quick pretreatment in the protein analysis process. 
 Hoven, et al. (2007) investigated protein adsorption characteristics of positively 
charged chitosan film (QAC film) and negatively charged chitosan film (SFC film). 
Protein solutions were freshly prepared by dissolving albumin, fibrinogen, lysozyme 
and ribonuclease in PBS at pH=7.4 to give a final concentration of 1 mg/ml. To reach 
an equilibrium hydration, the film substrate was immersed in the PBS solution 
overnight prior to adsorption. Each sample was removed from PBS solution and 
suspended into the wells containing 3 ml protein solution before incubation at 37 0C for 
3 h. Then the films were removed and rinsed with 4x10 ml PBS solution to remove 
reversibly adsorbed protein. To remove irreversibly adsorbed protein from the film 
surface, each film was transferred to another vial containing 2.0 ml of 1.0 wt% sodium 
dodecyl sulfate (SDS) and soaked for 1 h at room temperature. To determine the total 
amount of protein adsorbed on the substrates, Bicinchoninic acid (BCA) protein assay 
was utilized. The absorbance of the solution was measured at 562 nm by UV-VIS 
spectroscopy (Microtiter plate reader; model Sunrise, Tecan Austria GmbH). The 
amount of adsorbed protein was determined by comparison of the absorbance of the 
samples with a calibration curve. Three repetitions were performed for all samples. 
With respect to chitosan films, the adsorbed amounts of all proteins on SFC films are 
shown in Figure 4.9.  
The proteins used in this investigation include albumin (BSA), fibrinogen (FIB), 
ribonuclease (RNase), and lysozyme (LYZ).  BSA and FIB were selected as models of 
negatively charged proteins, whereas RNase and LYZ represent proteins carrying a 
positive charge. The protein concentration of 1 mg/ml used in adsorption studies is in 
the plateau region of the adsorption isotherm determined for all four proteins. 
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Figure 4.9. Amount of adsorbed proteins on QAC films in comparison with chitosan 
films 
                  (Source: Hoven, et al. 2007) 
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CHAPTER 5 
 
EXPERIMENTAL 
 
5.1. Materials  
 
Polymeric material used in this study was low molecular weight chitosan and 
commercial hydroxyapatite purchased from Sigma-Aldrich. Acetic acid (glacial), 
purchased from Merck, was used as a solvent after dilution by deionised water, for the 
preparation of the polymer solution. Properties of materials used for the production of 
scaffolds are given in Table 5.1.  Protein used was Bovine Serum Albumin (BSA) from 
Sigma. Properties of BSA are given in Table 5.2. 
 
Table 5.1. Properties of Materials Used in This Study 
 
 Hydroxyapatite Acetic Acid Chitosan 
Chemical Formula Ca10(PO4)6(OH)2 CH3COOH --- 
Molecular weight (g/mol) 1004.6 60.05 --- 
Density (g/cm3) 3.14 1.05 1.51 
 
 
Table 5.2. Properties of Bovine Serum Albumin 
 
Molecular weight (g/mol) 66.700 
Dimensions (nm) 4x4x14 
Density (g/cm3) 1.36 
Isoelectric point (pI) pH 4.7-4.9 
 
Human Serum Protein (HSP) used for the adsorption studies was collected from 
blood serum of 5 healty volunteers. The serum protein amount was measured as 
680mg/ml and stored in the freezer at -20 0C for stock protein solution. 
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Buffer solutions prepared for the adsorption experiments were as follows: 
• 0.2 M monobasic sodium phosphate stock solution (13.9 g NaH2PO4.H2O was 
dissolved in deionized water and diluted to 500 ml). 
 
• 0.2 M dibasic sodium phosphate stock solution (14.2 g Na2HPO4 was dissolved 
in deionized water and diluted to 500 ml). 
 
• 10 mM Sodium phosphate buffer solution (PBS) (34.5 ml dibasic stock solution 
and  15.5 ml monobasic stock solution  were mixed and diluted to 1000 ml  with 
deionized water) for pH=7.4. 
 
• 10 mM Sodium phosphate buffer solution (PBS) (2 ml dibasic stock solution 
and  48 mlmonobasic stock solution  were mixed and diluted to 1000 ml  with 
deionized water) for pH= 5.7. 
 
• Simulated body fluid (SBF) was prepared by dissolving the reagent grade 
chemicals through the addition of the respective amounts in the following order: 
NaCl, NaHCO3, KCl, Na2HPO4, MgCl2.6H2O, CaCl2, and NaSO4 in deionized 
water.The composition of SBF and plasma are given in Table 5.3.  The solution 
was buffered at physiological pH of 7.4 at 370C with 50 mM trishydoximethyl 
aminomethane [(CH2OH)3 (CNH2)] (THAM) and 36.23 mM of HCl acid. Most 
of the HCl was added before the CaCl2 addition and the pH was adjusted with 
HCl acid after THAM addition.  
 
Table 5.3. Ion concentrations (mM) of simulated body fluid (SBF) and human blood 
plasma 
  
                      Na+        K+             Ca2+      Mg2+    Cl-      HCO3-    HPO4-    SO4-    buffer   
Plasma          142     5.0        2.5       1.5     103    27            1.0      0.5     - 
SBF              142    5.0        2.5        1.5     125   27             1.0      0.5     THAM 
 
 
 
 38
5.2. Methods  
 
5.2.1. Freeze- Drying Method for Porous Chitosan/ HA Production  
 
The chitosan/hydroxyapatite composites were coded as C100H0 to C20H80. 
The composites and their compositions are in Table 5.4. 
 
Table 5.4. wt %  of hydroxyapatite and chitosan in Chitosan/ HA composites 
 
wt % SAMPLE     
HA  CHITOSAN 
C100H0 0 100 
C80H20 20 80 
C70H30 30 70 
C50H50 50 50 
C30H70 70 30 
C20H80 80 20 
 
Acetic acid was used as the solvent to prepare the polymer solutions.  By using 2 
v/v % acetic acid solution, chitosan was dissolved by using magnetic stirrer for 3h and 
the polymer solution was left overnight at room temperature to remove the air bubbles 
trapped in the viscous solution. Then predetermined amount of hydroxyapatite was 
dispersed in deionised water by 30 min ultrasonic treatment. Ultrasonic treatment was 
necessary to avoid agglomeration of ceramic powder and to achieve proper dispersion. 
Hydroxyapatite in water was mixed with polymer solution under agitation. In all the 
samples chitosan amount was fixed and hydroxyapatite amount was changed. The 
homogeneously mixed solution was poured in a syrnge which was used as cylindrical 
moulds and immediately taken to deep freeze at –20 oC and –80 oC. After 24 h freezing 
the samples were quickly placed into the freeze drier (Labconco) containers and freeze 
dried for 30-36 hours. A picture of the freeze drier used in this work is shown in Figure 
5.1. 
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Figure 5.1. The picture of LABCONCO Freeze Dryer used for the preparation of 
composites in this work 
 
The freeze dried composites were further dried at 35oC for 48h. Finally the 
samples were cut into discs and used for SEM and protein adsorption measurements. 
 
5.2.2. Characterization of Composites 
 
Scanning Electron Microscopy (SEM) (Philips XL 30SFEG) was used to 
determine the morphology of the composites. The porosities and densities of the 
composites were determined by determining their dimensions and weight. The density 
of of the starting chitosan powder was determined by using Helium pycnometer. Weight 
loss curve of scaffolds were determined by thermogravimetric analysis (TGA) using a 
Shimadzu TGA-51 instrument with a constant heating rate of  4 0C /min up to 1000 0C 
under a dry N2 stream. Differential Scanning Calorimetry (DSC Shimadzu ) and Fourier 
Transform Infrared Spectrophotometer (FTIR Shimadzu 8201) analysis were also 
carried out.  
 
5.2.3. Adsorption Studies and Bradford Method for Determination of 
Adsorbed BSA 
            
Protein solutions were freshly prepared by dissolving albumin in PBS at pH=7.4 
and 5.7 to give a final concentration of 1 mg/ml. Scaffolds (40 mg) were soaked in 100 
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% ethanol for an hour and in phosphate buffer solution   (PBS) for 30 min twice. Each 
sample was removed from PBS solution and suspended in the tubes containing 5 ml 
protein solution and incubated at 37 0C for 3 h. In some experiments concentration of 
BSA solution was fixed and different scaffold samples were used for the adsorption 
studies. Other experiments were carried out with various BSA concentrations (0.1- 1 
mg/ml) using the same sample. The adsorption was conducted under constant 
temperature of 37 ◦C for 3 hours in a thermal shaker at 150 rpm. Then the scaffolds 
were centrifuged and the supernatant was saved for protein concentration determination. 
The amount of protein in the supernatant was quantified by the absorbance at 595 and 
280 nm using a UV spectrophotometer. The amount of adsorbed protein was determined 
by comparison of the absorbance of the samples with a calibration curve. 
 The wetted scaffolds were incubated in bovine serum albumin solutions for 3 h 
on the shaker (150 rpm).  After the 3 h incubation period, the scaffold was removed 
from the protein solution The remaining proteins in the solution was measured using 
Bradford protein assay at 595 nm or absorbance assay at 280 nm in quartz cuvettes. 
Absorbance assay at 280 nm was fast and convenient, since no additional 
reagents or incubations were required. Proteins in solution absorb UV light with 
absorbance maximum at 280 nm. Amino acids with aromatic rings are the primary 
reason for the absorbance peak at 280 nm. 
Bradford protein assay depends on the prencibles of complexing Coomassie 
Brillant Blue with proteins to give an absoption maximum at 595 nm.  It is a simple 
method with colour developing rapidly to produce a stable complex and is sensitive 
dawn to 40 µg protein per ml. Bradford’s solution was prepared by dissolving 100 mg 
Coomassie Brillant Blue G-250 in 50 ml ethanol (95 %) , adding 100 ml of phosphoric 
acid (85 % w/v) and diluting to 1 liter with deionized water, respectively. Solution was 
filtered through the filter paper into a dark bottle and stored at  +4 oC.  For absorbance 
measurement, spectrophotometer was switch on and allowed to warm up at least 15 
min. 1000 µL sample and the 1000 µL of the dye reagent accurately pipetted, fixed in 
the vortex and incubated for 15 min at room temperature. Absorbance was measured at 
595 nm. The concentration of sample was obtained from a standard curve obtained by 
using known concentrations of standard protein ( BSA).  
Standard calibration curve obtained by using BSA protein standard (Sigma) was 
plotted using Bradford protein assay. Standard curve was obtained by using bovine 
serum albumin solutions (BSA) with concentrations of 0, 4, 10, 20, 30, 40 µg/ml for the 
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standard assay. After carried out Bradford Protein Assay procedure absorbance of these 
concentrations were measured at 595 nm.  A calibration curve was prepared by plotting 
the absorbance values of the standarts versus their corresponding protein concentrations. 
These protein concentrations were further multiplied with the dilution factors in order to 
obtain the actual protein concentrations in the orginal sample (c). Calibration curve at 
280 nm was also plotted with the BSA protein standard.  Using these standard curves 
the concentration for an unknown sample was estimated at the given absorbance 
reading. These three calibration curves (BSA at 595 and 280 nm, and HSP at 280 nm) 
are given in the Appendix. 
After BSA equilibrium concentrations were determined, the amount of BSA 
adsorbed on scaffolds was calculated from the following equation: 
( )cc
W
Vq
s
−= 0                                                       (9) 
Where co is the initial BSA concentration in the solution, c is the equilibrium BSA 
concentration, V is the sample volume, and the Ws is the amount of composite scaffold 
used. Adsorption isotherms were obtained for each pH value plotting q(amount of BSA 
adsorbed on scaffold, mg BSA/g sample) versus equilibrium concentration of BSA (c) 
in the solution.  
 Batch kinetic experiments were carried out to determine the amount of BSA 
adsorbed on scaffolds against time. 40 mg composite scaffold was added to 5 ml protein 
solution with identical experimental conditions with adsorption isotherm 
determinations. Samples from  the tubes were taken out at certain time intervals, a 
similar procedure was followed as described earlier in adsorption isotherm experiments 
and q versus t plots were prepared. 
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CHAPTER 6 
 
RESULTS AND DISCUSSION 
 
In this study the preparation, characterization and protein adsorption behaviour 
of porous hydroxyapatite/chitosan scaffolds were investigated. The effects of processing 
parameters like the HA/chitosan ratio and pH on protein adsorption onto HA/chitosan 
composite biomaterials were examined and discussed. The difficulties in the UV based 
absorbance measurement methods at 595 and 280 nm for the protein (BSA and HSP) 
concentration determination, the reliability and reproducibility of this data together with 
the degradation tendency of freeze-dried chitosan have been discussed and reported. 
 
6.1. Characterization of Porous Hydroxyapatite /Chitosan composites 
 
The physical, microstructural and thermal properties of chitosan / HA composite 
scaffold biomaterials varies with the increasing HA content. The estimated theoretical 
densities ( from the theoretical densities of the pure components HA and chitosan 3.16 
and 1.52g/cc respectively), the bulk densities from dimensions and weights of 
composite samples. 
 As can be seen in Table 6.1. and Figure 6.1. when chitosan amount decreased 
and hydroxyapatite content increased the density of the composite increased which led 
to a decrease in porosity. C20H80 had the lowest porosity and highest density while 
C100H0 had the lowest density and highest porosity.  The composites had porosities in 
the 93.5-96.25 % range where the density of the freeze-dried pure chitosan scaffold had 
the lowest density of 0.057 g/cc. Since the total volume of the frozen polymer/HA 
dispersions were kept approximately constant at about 40 ml, the density of the freeze-
dried composites increased as the HA content increased.  There seems to a relatively 
faster change in the porosity level in the 30-60% Chitosan composites as seen in Figure 
6.1.   
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Table 6.1. Densities of HA/Chitosan composites 
 
TD % Chitosan density % of TD % porosity 
2.604 20 0.17 6.53 93.47 
2.392 30 0.148 6.19 93.81 
2.053 50 0.106 5.16 94.84 
1.923 60 0.0875 4.55 95.45 
1.802 70 0.074 4.11 95.89 
1.696 80 0.067 3.95 96.05 
1.52 100 0.057 3.75 96.25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1. The variation of density and porosity of the chitosan composites with 
composition 
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The SEM images of the hydroxyapatite/chitosan composites are given in Figures 
6.2. through 6.7. When all the SEM images of composites are considered highly porous 
structure was common in all these materials. The smoothest surface at pure chitosan 
began to be disturbed with incorporation of hydroxyapatite gradually resulting in a 
rough surface which was not smooth anymore. The HA particles were embedded well in 
the chitosan matrix. The pore sizes were around 50–250 μ.  
                                    
    
 
 
 
 
 
      
   
 
 
 
 
 
 
 
 
 
 
Figure 6.2. Scanning electron (SEM) micrographs of C100H0 composites frozen at -20 
0C before freeze drying 
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Figure 6.3. Scanning electron (SEM) micrographs of C100H0 composites frozen at -80 
0C before freeze drying 
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Figure 6.4. Scanning electron (SEM) micrographs of C50H50 composites frozen at -20 
0C before freeze drying 
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Figure 6.5. Scanning electron (SEM) micrographs of C50H50 compositesfrozen at -80 
0C before freeze drying 
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Figure 6.6. Scanning electron (SEM) micrographs of C30H70 composites frozen at -20 
0C before freeze drying 
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Figure 6.7. Scanning electron (SEM) micrographs of C30H70 composites frozen at -80 
0C before freeze drying 
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Increasing hydroxyapatite content did not disturb the porous structure exceptally 
some C30H70 70wt HA,  the effect of HA on the morphology was significant. The 
pores decreased in size, cavities between cells became thin, uniformity decreased and 
surface became rough, in some samples lameller structure was observed.  
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Figure 6.8. The Thermogravimetry (TGA) curves for low molecular weight raw 
chitosan, C100H0, C50H50 and chitosan film 
 
 
The TGA curves of the raw unprocessed low molecular weight chitosan along 
with two composites (C100H0 and C50H50) and the film prepared by room 
temperateure drying of chitosan-acetic acid clear solution is given in Figure 6.8.  The 
DSC curves of low and medium molecular weight chitosan, the same composites and 
the film are given in Figures 6.9. through 6.11.There is an initial weight loss of about 
10-15% in all TGA curves up to 100-150oC in all four samples which most likely is due 
to the removal of water from the structures. This was in good aggreement with the 
endothermic low temperature peaks observed below 100oC in all DC curves.  
Significant differences in the TGA curves in the 150-300oC range were observed as 
seen in Figure 6.8. Although there was a temperature range (approximately 150-280oC) 
with almost no weight loss in the TGA curve of unprocessed raw low molecular weight 
chitosan, in the same internal there were significant weight losses in all the other TGA 
curves. This indicates that the structure changes upon dissolution in the acetic acid 
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solution and freeze drying and becomes less ordered and easier to degrade upon heating 
in that range. The relatively sharp weight loss curve becomes wider. 
 The steep exothermic peaks observed in all DSC curves at about 290-310oC is in 
aggreement with the TGA behaviour and was most likely due to thermal degradation of 
the biopolymer. There are extra peaks located at about 240oC for the two freeze-dried 
composites. The reason for their presence may be related to the removal of acetic 
acid/acetyl groups from the porous/high surface area polymeric matrix relatively easy at 
that lower temperature range. 
 
 
Figure 6.9. Differential Scanning Calorimeter (DSC) curvesfor C100H0 and C50H50 
chitosan composites 
                               
 
 
Figure 6.10. Differential Scanning Calorimeter (DSC) curves for Chitosan film 
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Figure 6.11. Differential Scanning Calorimeter (DSC) curves for medium and low 
molecular weight Chitosan film 
 
6.2. Adsorption of BSA onto Chitosan/HA Composite Scaffolds 
 
Uptake of BSA by chitosan/HA composite (C50H50) at time scale for two pH 
values are given in Figures 6.12-6.14. The effect of pH on uptake profiles at a fixed 
initial BSA concentration (C0=1 mg/ml) have been investigated by using 280 and 595 
nm UV-based concentration determination methods.  The presence of an initial rapid 
adsorption period (which was approximately in the 120-180 minutes range) is evident in 
all the three plots where more than 75% of the total adsorption takes place. For the 
C50H50 composite (determined to be 95% porous) the maximum BSA uptake levels 
were about 80 mg/g composite and was independent of pH and UV method. It was 
assumed that adsorption equilibrium was achieved in 3 hours in the rest of this work 
based on this observation. 
The freeze dried pure chitosan and chitosan/HA composites were observed to 
swell considerably upon soaking in aqueous solutions thus a large amount of solution is 
enclosed in the gel-like swollen composite structure. This necessitated the common 
application in earlier work by other researchers the NaOH (through the neutralization of 
the surface acidic functional groups) and ethanol soaking pretreatments (Zhao, et al. 
2000) or copolymerization of the starting biopolymer in order to stabilize the structure. 
Since chitosan is a biodegradable polymer, the influence of its degradation/swelling 
tendency/unstability on the protein adsorption equilibrium was investigated by soaking 
the C50H50 composite in the pH=5.7 buffer and following the absorbance of the 
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supernatant by the Bradford method at 595 nm as a function of time. The result of this 
work is given as % of original soaked composite dissolved in the buffer as a fuction of 
time in Figure 6.15. The presence of a rapid initial dissolution stage of chitosan in the 
first two hours of soaking in the pH=5.7 buffer accounting for almost about 5wt% 
dissolution of the original composite is evident in Figure 6.15.  The dissolution level 
somewhat stabilized in the 5-7 wt% range for up to 24 h of soaking. The raw chitosan 
(RC) was dissolved in acetic acid solution similarly to the composite preparation and a 
standard calibration curve (similar to the standard calibration curves for BSA and HSP 
given in the Appendix) was obtained with the Bradford method at 595 nm and is given 
in Figure 6.16. This was done in order to see whether dissolved chitosan reacted with 
the dye used in the Bradford method and caused absorbance during the concentration 
determination. Although the dissolution of chitosan was quantified the calibration curve 
leveled of, which for accurate determination must diplay a linear relation between the 
absorbance and the concentration. Due to the presence of dissolution and interference 
from the chitosan present in the solution, blank chitosan samples were soaked in the 
respective media and the absorbance values were corrected with these blank values in 
the rest of this work for accurate protein concentration determination in the 
supernatants. 
 
         
 
 
 
 
 
 
 
 
 
Figure 6.12. Uptake of BSA by C50H50 at pH=7.4 
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Figure 6.13. Uptake of BSA by C50H50 at pH=7.4 
 
 
            
 
 
 
 
 
 
 
 
Figure 6.14. Uptake of BSA by C50H50 at pH=5.7 and 595 nm 
 
 
           
 
 
 
 
 
 
 
 
 
Figure 6.15. Chitosan dissolution of C50H50 at pH=5.7 
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Figure 6.16. Chitosan concentration versus absorbance reading with varying amounts of 
raw chitosan at 595 nm (bradford method) 
 
 
 The BSA uptake of pure freeze-dried chitosan C100H0, C70H30, C50H50, 
C30H70, and pure HA powder in the pH=5.7 and pH=7.4 phosphate buffers were 
determined by two methods (280 nm and 595 nm Bradford) and are given in the form of 
bar graphs in Figures 6.17. and 6.18.  It is clearly evident in both graphs that the 595 nm 
Bradford UV-based protein concentration determination results in sligtly higher uptake 
levels than the 280 nm based method which does not make use of any dyes. The freeze-
dried composites have sligtly higher uptake values compared to the unprocessed as-
received raw chitosan at pH=7.4.  The uptake levels can reach up to about 55-60 mg/g 
range in the 595 nm method and to the 40-60 mg/g range for the 280 nm method. The 
uptake levels at pH=7.4 for the C70H30 and C50H50 composites are relatively higher 
than the pure freeze-dried chitosan and significantly higher than the raw as-received 
flaked chitosan. This is most likely due to the structural changes occurring during freeze 
drying and the introduction of the second phase into the composite and the significantly 
higher surface area generated during the preparation compared to the raw chitosan. 
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Figure 6.17.  Comparison of BSA uptake at 3 hours pH=5.7 for composites and HA 
powder at 595nm and 280nm 
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Figure 6.18.  Comparison of BSA uptake at 3 hours pH=7.4 for composites and HA 
powder at 595nm and 280nm 
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The BSA uptake of composites and HA powder pretreated by soaking in about 2 
ml of 0.1M NaOH and 99.5% ethanol for 1 hour in SBF (pH=7.4) is given in Figures 
6.19. and 6.20. for 280 nm and 595 nm Bradford methods respectively. The uptake of 
BSA by these composites were significantly lower in SBF solutions than the previously 
discussed pH=5.7 and pH=7.4 buffer solutions. The BSA uptake values were in the       
6-8 mg/g and 10-22 mg/g ranges for 280 nm and 595 nm Bradford methods respectively 
compared to the 40-60 mg/g and 45-60 mg/g ranges discussed previously for the 
pH=7.4 and pH=5.7 buffer solutions. This represents approximately 6-10 fold decreases 
in the BSA uptake levels in SBF solutions. The reasons for this significant difference at 
pH=7.4 may be likely to be due to the differences in the chemistry of the two solutions. 
There were also differences in the BSA uptake behaviour of the composites with the 
nature of pretreatment as can be seen from Figures 6.19. and 6.20. The one hour soaking 
in ethanol causes in general for all composites slightly higher BSA uptakes. The uptake 
values determined by using the 595 nm Bradford method as previously stated were 
significantly higher than the 280 nm method in the SBF solutions, too.  
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Figure 6.19. BSA uptake at 3 hours in SBF ( pH=7.4) for composites and HA powder 
treated with NaOH and Ethanol 
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Figure 6.20. Compare of BSA uptake at 3 hours in SBF ( pH=7.4) for composites and 
HA powder treated with Ethanol and NaOH (595 nm) 
 
 The BSA adsorption isotherms of C100H0 and C70H30 at pH= 7.4 buffer is 
seen in Figures 6.21. and 6.22. for 280 nm method. The BSA uptake of composites 
increased as the initial concentration of BSA solution increased. The adsorption 
isotherms of the composite materials determined in this work mostly didn’t have an 
acceptable fit to the commonly known adsorption isotherms of Langmuir and 
Freundlich. The composites investigated in this work were not regular solid adsorbents 
(with fixed boundary/adsorption surface/adsortion site number and nature) but had a 
swelling nature with most likely increasing surface area/adsortion site nature and 
numbers during the course of BSA/HSP adsorption process. The unstability in the 
isotherms along with their unfavourable nature can most probably be explained with the 
structure of these freeze-dried biodegradable composites. 
 
                       
 
 
 
 
 
 
Figure 6.21. Adsorption isotherm of C100H0 at pH=7.4 at 280 nm 
0
10
20
30
40
50
60
70
80
90
0.00 0.10 0.20 0.30 0.40
C(mg/ml)
q(
m
gB
SA
/g
 S
am
pl
e)
280nm
 59
              
 
 
 
 
 
 
 
 
 
Figure 6.22. Adsorption isotherm of C70H30 at pH=7.4 at 280 nm 
  
Adsorption isotherms of C50H50 obtained from two different sets of 
experiments in pH=7.4 buffer with 280 nm method is given in Figure 6.23a. The data of 
the first run was further fitted to a Langmuir model equation as given in Figure 23b.  
The 1/q vs.1/c plot for this model is further given in Figure 23c. The qm and K values for 
this fit was determined as 93.46 mg/g and 0.39 mg/ml respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.23a. Adsorption isotherm of C50H50  at pH=7.4 at 280 nm 
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Figure 6.23b. Adsorption isotherm of C50H50 at pH=7.4 at 280 nm 
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Figure 6.23c. Reciprocal plot for BSA adsorption on C50H50 at pH=7.4 at 280 nm 
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Figure 6.24. Adsorption isotherm of composites in SBF( pH=7.4) at 280 nm 
 
 
            
 
 
 
 
 
 
 
 
 
Figure 6.25. Adsorption isotherm of C50H50 at pH=7.4 at 595 nm 
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Figure 6.28. The uptake of HSP by the C50H50 and C70H30 composites is similiar 
with the others about 50-60 mg/g and 50-70 mg/g for 280 nm and 595 nm methods 
respectively. The adsorption of HSP is alot more favourable on the freeze-dried 
composites prepared in this work when compared with unprocessed raw flaked chitosan 
as is clearly seen in Figure 6.26. This may be an important advantage for these 
candidate scaffold biomaterials for enhanced biocompatibility. 
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Figure 6.26. HSP uptake at 3 hours ( pH=7.4) for composites 
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Figure 6.27. HSP uptake at 3 hours ( pH=7.4) for composites 
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Figure 6.28. Adsorption isotherm of C50H50 at pH=7.4 
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CHAPTER 7 
 
CONCLUSIONS  
 
Biocompatibility is an essential prequisite for a successful functioning of any 
implant and the initial necessary phase of biocompatibility involves the adsorption of 
blood serum proteins onto the biomaterial surfaces which is followed by cell attachment 
onto the implant surfaces. Composite biomaterials formed from biodegradable chitosan 
biopolymer and the inorganic component of natural bone presents a unique combination 
for scaffold resorbable biomaterials. The preparation and characterization of porous 
chitosan/hydroxyapatite porous scaffold composites was conducted by freeze drying 
and BSA and HSP adsorption onto these scaffolds were investigated in this work.  
 Porous scaffolds with seven different Chitosan/HA contents with 93.5-96.3% 
porosity was prepared. The SEM images showed that the composites have a 
homogeneous and porous microstructure with pore sizes in the 50-250μ range The TGA 
curves have shown that the freeze dried phase separation induced biopolymer structure 
degrades at lower temperatures faster than the original raw polymer.  
 Two different UV based protein concentration determination methods, the 595 
nm Bradford method which involved the use of dye solutions and the direct absorption 
at 280 nm by the protein solution, were used in this work. The adsortion uptake values 
obtained by these methods were a little different with the Bradford method and the 280 
nm method determinations. Due to the use of dyes, dilutions during UV absorbance 
measurements, and the operator dependent nature of the 595 nm Bradford method, it is 
believed that the direct protein solution absorbance UV absorbance based 280 nm 
method was more reliable and accurate.  The BSA absorption kinetics studies have 
shown that the equilibrium may be reached in about 2-3 hours with as high as 40-60 
mg/g BSA adsorption on the scaffolds by the 280 nm method.  The equilibrium 
adsorption behaviour of these composites didn’t fit to the commonly known Langmuir 
and Freundlich isoterms except in one run.  The swelling/degradation tendency of the 
biopolymer in the buffer solutions and the unstable nature of the adsorption surface/its 
chemical nature was held responsible for the observed adsorption behaviour. An 
 65
important finding of this work was the 6-10 fold lower BSA adsorption on these 
composites in SBF solutions than the pH=5.7 and 7.4 buffer solutions. 
 The composite structure must be stabilized by various techniques for accurate 
protein adsortion research. There has to be an optimum in the level of stalibizatioon 
since biodegradation/resorbtion of the scaffold may certainly be a significant advantage 
of these composites. The mechanical properties along with in situ bone growth and the 
the microstructural changes occurring during this process should be investigated in the 
future. 
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APPENDIX A 
 
STANDARD CURVES FOR PROTEIN ABSORPTION  
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Figure A.1. BSA 595 nm Bradford method standard calibration curve 
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Figure A.2. BSA 280 nm standard calibration curve 
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Figure A.3. HSP 280 nm standard curve 
